Stock TFFP TFF PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus TFF Pharmaceuticals, Inc.

Equities

TFFP

US87241J2033

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.06 USD +0.49% Intraday chart for TFF Pharmaceuticals, Inc. -6.79% -70.66%
May. 23 TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing MT
May. 23 TFF Pharmaceuticals, Inc. and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing CI

Evolution of the average Target Price on TFF Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

869ef17d3d9a.66i__8sOFsymjsOeArDXXGtyvc5gY6iBZMCd_F6K8_k.vN3wmfl6L6Ke3bvYasKhCh8Divc2G9jMF_PylB3khbyP_8iP5lxu9JK_gg~fa925a5485cc3e0defafe48778cd58b4

Analyst Recommendations on TFF Pharmaceuticals, Inc.

Roth MKM Cuts TFF Pharmaceuticals' Price Target to $44 From $56, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on TFF Pharmaceuticals to $4 From $22, Maintains Buy Rating MT
JonesTrading Starts TFF Pharmaceuticals at Buy With $7 Price Target MT
US Futures Nudge Higher Ahead of Federal Reserve Board Meeting; Fourth Straight Rate Hike Expected MT
B. Riley Lowers TFF Pharmaceuticals' Price Target to $18 from $24 Mainly to Reflect Delays Noted with Select Pipeline, Corporate Milestones; Keeps Buy Rating MT
TFF PHARMACEUTICALS : B. Riley Lowers TFF Pharmaceuticals' PT to $24 from $31 on Expanding R&D Spend, Minor Delays on Pipeline Milestones; Keeps Buy Rating MT
TFF PHARMACEUTICALS : B. Riley Lowers TFF Pharmaceuticals' PT to $31 from $36 Driven by Research and Development Spend Growth, Keeps Buy Rating MT
TFF PHARMACEUTICALS : HC Wainwright & Co. Adjusts Price Target on TFF Pharmaceuticals to $37 From $31, Maintains Buy Rating MT
TFF PHARMACEUTICALS : Roth Capital Adjusts Price Target on TFF Pharmaceuticals to $27 From $23, Maintains Buy Rating MT
TFF PHARMACEUTICALS : HC Wainwright Starts TFF Pharmaceuticals at Buy With $31 Price Target MT
TFF PHARMACEUTICALS : B. Riley Initiates TFF Pharmaceuticals at Buy With $36 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.06 USD
Average target price
17 USD
Spread / Average Target
+725.24%
High Price Target
30 USD
Spread / Highest target
+1,356.31%
Low Price Target
4 USD
Spread / Lowest Target
+94.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering TFF Pharmaceuticals, Inc.

Roth MKM
HC Wainwright
JonesTrading Institutional Services
B. Riley

Ratings for TFF Pharmaceuticals, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TFFP Stock
  4. Consensus TFF Pharmaceuticals, Inc.